Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edo Richard

Showing results (41-50 of 199) with videos related to

Pageof 20
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 24, 2023
The challenge of dementia prevention trials and the role of quasi-experimental studiesJosephine E Lindhout, Jan Willem van Dalen, Willem A van Gool, et al.
The Lancet. Healthy Longevity|November 4, 2023
Evaluation of clinical benefits of treatments for Alzheimer's diseaseKathy Y Liu, Sebastian Walsh, Carol Brayne, et al.
Neuroimage. Clinical|August 15, 2022
Atherosclerotic risk is associated with cerebral perfusion - A cross-sectional study using arterial spin labeling MRIMelanie Hafdi, Henk Jmm Mutsaerts, Jan Petr, et al.
Journal of Clinical Medicine|June 20, 2019
A Population Perspective on Prevention of DementiaEsmé Eggink, Eric P Moll van Charante, Willem A van Gool, et al.
Journal of Alzheimer'S Disease : JAD|July 20, 2012
The Alzheimer myth and biomarker research in dementiaEdo Richard, Ben Schmand, Piet Eikelenboom, et al.
European Journal of Preventive Cardiology|September 21, 2011
Cardiovascular risk management in community-dwelling elderly: opportunities for preventionSuzanne A Ligthart, Edo Richard, Willem A van Gool, et al.
Brain Imaging and Behavior|October 28, 2016
Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of MeynertJan Willem van Dalen, Matthan W A Caan, Willem A van Gool, et al.
Journal of Hypertension|February 26, 2025
Day-to-day blood pressure variability in older persons - optimizing measurementTanya Palsma, Jurgen A H R Claassen, Edo Richard, et al.
Vascular Health and Risk Management|September 23, 2010
Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic reviewSuzanne A Ligthart, Eric P Moll van Charante, Willem A Van Gool, et al.
Journal of the American Medical Directors Association|February 11, 2019
Discontinuation of Antihypertensive Medication, Cognitive Complaints, and Incident DementiaJan Willem van Dalen, Eric P Moll van Charante, William A van Gool, et al.
Pageof 20

Showing results (41-50 of 199) with videos related to

Sort By:
Pageof 20
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 24, 2023
The challenge of dementia prevention trials and the role of quasi-experimental studiesJosephine E Lindhout, Jan Willem van Dalen, Willem A van Gool, et al.
The Lancet. Healthy Longevity|November 4, 2023
Evaluation of clinical benefits of treatments for Alzheimer's diseaseKathy Y Liu, Sebastian Walsh, Carol Brayne, et al.
Neuroimage. Clinical|August 15, 2022
Atherosclerotic risk is associated with cerebral perfusion - A cross-sectional study using arterial spin labeling MRIMelanie Hafdi, Henk Jmm Mutsaerts, Jan Petr, et al.
Journal of Clinical Medicine|June 20, 2019
A Population Perspective on Prevention of DementiaEsmé Eggink, Eric P Moll van Charante, Willem A van Gool, et al.
Journal of Alzheimer'S Disease : JAD|July 20, 2012
The Alzheimer myth and biomarker research in dementiaEdo Richard, Ben Schmand, Piet Eikelenboom, et al.
European Journal of Preventive Cardiology|September 21, 2011
Cardiovascular risk management in community-dwelling elderly: opportunities for preventionSuzanne A Ligthart, Edo Richard, Willem A van Gool, et al.
Brain Imaging and Behavior|October 28, 2016
Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of MeynertJan Willem van Dalen, Matthan W A Caan, Willem A van Gool, et al.
Journal of Hypertension|February 26, 2025
Day-to-day blood pressure variability in older persons - optimizing measurementTanya Palsma, Jurgen A H R Claassen, Edo Richard, et al.
Vascular Health and Risk Management|September 23, 2010
Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic reviewSuzanne A Ligthart, Eric P Moll van Charante, Willem A Van Gool, et al.
Journal of the American Medical Directors Association|February 11, 2019
Discontinuation of Antihypertensive Medication, Cognitive Complaints, and Incident DementiaJan Willem van Dalen, Eric P Moll van Charante, William A van Gool, et al.
Pageof 20